Calif. biotech startup gets $20M funding boost

05/30/2013 | MedCityNews.com

Kite Pharma, a California-based biotech focused on developing novel cancer immunotherapies, secured $20 million in its latest funding round. Kite has access to the National Cancer Institute's pipeline of engineered autologous peripheral blood T cells that can be targeted to multiple hematological and solid tumor types.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT